HT-0712

DB11650InvestigationalSmall molecule

BLX-028914 has been used in trials studying the treatment and basic science of Allergic Rhinitis and Age-Associated Memory Impairment (AAMI).

Chemical structure of HT-0712
Mechanism
Curator reviewed
Formula / weight
C25H31NO3 · 393.527 g/mol (avg)
Code names
BLX-028914 · IPL-455903 · OX-914

Resolves to

Compound
UNII2O43FXG9IGCAS617720-02-2PubChem9865375
Structure
InChIKeyABEJDMOBAFLQNJ-NHCUHLMSSA-NSMILESCOC1=CC=C(C=C1OC1CCCC1)[C@H]1CNC(=O)[C@H](CC2=CC(C)=CC=C2)C1
Targets
Q07343PDE4BP27815PDE4AQ08499PDE4D

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with HT-0712, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In